THC Farmaceuticals, Inc. (CBDG)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -4952.00 USD | -179.97% |
| 2022 | 6192.00 USD | 383.0% |
| 2021 | 1282.00 USD | -83.08% |
| 2020 | 7575.00 USD | 0.21% |
| 2019 | 7559.00 USD | -38.08% |
| 2018 | 12.2 Thousand USD | -5.72% |
| 2017 | 12.94 Thousand USD | -24.16% |
| 2016 | 17.07 Thousand USD | 0.0% |
| 2014 | 6.73 USD | 39.13% |
| 2013 | 4.84 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 Q3 | -952.00 USD | 0.0% |
| 2022 Q1 | 9048.00 USD | 0.0% |
| 2022 Q2 | -952.00 USD | -110.52% |
| 2021 FY | 1282.00 USD | -83.08% |
| 2020 FY | 7575.00 USD | 0.21% |
| 2020 Q1 | 5027.00 USD | 0.0% |
| 2019 Q3 | 6307.00 USD | 68.55% |
| 2019 FY | 7559.00 USD | -38.08% |
| 2019 Q2 | 3742.00 USD | 0.0% |
| 2018 FY | 12.2 Thousand USD | -5.72% |
| 2017 FY | 12.94 Thousand USD | -24.16% |
| 2016 FY | 17.07 Thousand USD | 0.0% |
| 2015 Q2 | 0.33 USD | -83.12% |
| 2015 Q1 | 1.93 USD | -7.39% |
| 2015 Q3 | - USD | -99.69% |
| 2014 Q2 | 2.18 USD | 171.23% |
| 2014 Q1 | 0.80 USD | 127.48% |
| 2014 FY | 6.73 USD | 39.13% |
| 2014 Q4 | 2.09 USD | 25.0% |
| 2014 Q3 | 1.67 USD | -23.42% |
| 2013 FY | 4.84 USD | 0.0% |
| 2013 Q2 | 2.10 USD | 0.0% |
| 2013 Q3 | 0.28 USD | -86.58% |
| 2013 Q4 | 0.35 USD | 25.18% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.042% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 98.45% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 89.739% |
| Qrons Inc. | - USD | Infinity% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 96.015% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.004% |
| Adynxx, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.981% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 103.525% |
| Arch Therapeutics, Inc. | -2439.00 USD | -103.034% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.033% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 259.639% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.051% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 107.534% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 85.499% |
| Mesoblast Limited | -35.16 Million USD | 99.986% |
| Marizyme, Inc. | 457.7 Thousand USD | 101.082% |
| Genus plc | 178.7 Million USD | 100.003% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 100.002% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 107.958% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 101.207% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 54.982% |
| ContraFect Corporation | -154 Thousand USD | 96.784% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 90.096% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 106.451% |
| IMV Inc. | -962.29 Thousand USD | 99.485% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 98.722% |
| MultiCell Technologies, Inc. | 49.32 USD | 10140.552% |
| ONE Bio Corp. | 20.12 Million USD | 100.025% |
| Accustem Sciences Inc. | - USD | Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.012% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 110.127% |
| Q BioMed Inc. | -8988.00 USD | 44.904% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.018% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 67.894% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.011% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 99.566% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 107.074% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 94.922% |
| GB Sciences, Inc. | -624.00 USD | -693.59% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 94.244% |
| HST Global, Inc. | - USD | Infinity% |
| CSL Limited | 7.56 Billion USD | 100.0% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -2280.769% |
| Enzolytics Inc. | 30.7 Thousand USD | 116.126% |
| Agentix Corp. | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 101.026% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | 1.1 Billion USD | 100.0% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 99.038% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 100.802% |
| Zenith Capital Corp. | - USD | Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.001% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 44.083% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 94.094% |
| Kadimastem Ltd | -630.13 Thousand USD | 99.214% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 100.501% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.052% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.032% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 58.158% |
| Cell Source, Inc. | - USD | Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 102.805% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 102.805% |
| NovAccess Global Inc. | - USD | Infinity% |
| Affymax, Inc. | 1.35 Million USD | 100.365% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| Mobile Lads Corp. | - USD | Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 82.924% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 101.1% |
| SYBLEU INC | 11.69 Thousand USD | 142.339% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 100.107% |
| Bioxytran, Inc. | -8285.00 USD | 40.229% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 98.672% |
| Neutra Corp. | 14.33 Thousand USD | 134.545% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 93.961% |
| PureTech Health plc | -1.6 Million USD | 99.691% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 99.505% |
| IXICO plc | 3.27 Million USD | 100.151% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 99.286% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 99.724% |
| CSL Limited | 7.7 Billion USD | 100.0% |
| Cellectis S.A. | 18 Thousand USD | 127.511% |